PT-141 Overview
PT-141, now known as Bremelanotide, is a synthetic melanocortin-receptor agonist developed from research into melanocortin peptides.
Unlike Melanotan compounds, PT-141 was developed primarily for research into sexual desire and arousal pathways.
Product Information
Bremelanotide acts on melanocortin receptors, particularly MC4R. Human clinical trials have investigated its effects on sexual-function measures in premenopausal women.
How Does PT-141 Work?
PT-141 activates melanocortin receptors in the central nervous system, influencing neural pathways associated with sexual motivation and arousal.
PT-141 Benefits & Effects
Supports Sexual-Function Research
Clinical trials have investigated Bremelanotide in women experiencing reduced sexual desire and have reported improvements in several sexual-function measures.
Influences Sexual-Desire Pathways
Unlike drugs that act primarily through blood-vessel relaxation, PT-141 works through melanocortin signaling in the central nervous system, making its mechanism particularly interesting.
Supports Arousal Research
Human studies have examined Bremelanotide in relation to sexual arousal, desire, orgasm, and distress associated with sexual dysfunction.
Supports Melanocortin Research
PT-141 provides an important tool for studying how melanocortin receptors influence behavior and sexual physiology.
PT-141 Side Effects
Common adverse effects include nausea, flushing, headache, vomiting, fatigue, dizziness, and temporary increases in blood pressure.
PT-141 Dosage
Clinical dose-finding research evaluated 0.75 mg, 1.25 mg, and 1.75 mg subcutaneous doses.
The currently approved pharmaceutical formulation uses 1.75 mg per dose, subject to its prescribing information.
Where to Buy PT-141?
PT-141 products are not sold by Purerawz. Purerawz may provide affiliate links to independent third-party websites.
Research Reference:
